Two oxytocin analogs, N- glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin

Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2023-02, Vol.18 (2), p.e0281363
Hauptverfasser: Cherepanov, Stanislav M, Yuhi, Teruko, Iizuka, Takashi, Hosono, Takashi, Ono, Masanori, Fujiwara, Hiroshi, Yokoyama, Shigeru, Shuto, Satoshi, Higashida, Haruhiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page e0281363
container_title PloS one
container_volume 18
creator Cherepanov, Stanislav M
Yuhi, Teruko
Iizuka, Takashi
Hosono, Takashi
Ono, Masanori
Fujiwara, Hiroshi
Yokoyama, Shigeru
Shuto, Satoshi
Higashida, Haruhiro
description Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with other uterotonics for cases of refractory uterine atony. However, as the effect of OT dose on uterine contraction and control of blood loss during cesarean delivery for labor arrest are highly associated with side effects, small amounts of uterotonics may be used to elicit rapid and superior uterine contraction. We have previously synthesized OT analogs 2 and 5, prolines at the 7.sup.th positions of which were replaced with N-(p-fluorobenzyl) glycine [thus, compound 2 is now called fluorobenzyl (FBOT)] or N-(3-hydroxypropyl) glycine [compound 5 is now called hydroxypropyl (HPOT)], which exhibited highly potent binding affinities for human OT receptors in vitro. In this study, we measured the ex vivo effects of FBOT and HPOT on contractions of uteri isolated from human cesarean delivery samples and virgin female mice. We evaluated the potency and efficacy of the analogs on uterine contraction, additivity with OT, and the ability to overcome the effects of atosiban, an OT antagonist. In human samples, the potency rank judged by the calculated EC.sub.50 (pM) was as follows: HPOT (189) > FBOT (556) > OT (5,340) > carbetocin (12,090). The calculated Emax was 86% for FBOT and 75% for HPOT (100%). Recovery from atosiban inhibition after HPOT treatment was as potent as that after OT treatment. HPOT showed additivity with OT. FBOT (56 pM) was found to be the strongest agonist in virgin mouse uterus. HPOT and FBOT demonstrated high potency and partial agonist efficacy in the human uterus. These results suggested that HPOT and FBOT are highly uterotonic for the human uterus and performed better than OT, indicating that they may prevent postpartum hemorrhage.
doi_str_mv 10.1371/journal.pone.0281363
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A736413254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A736413254</galeid><sourcerecordid>A736413254</sourcerecordid><originalsourceid>FETCH-LOGICAL-g674-2e2069ffa4afdca90e5d0cb0819d9de53dc045e99d30250f18fb492bf74fed7e3</originalsourceid><addsrcrecordid>eNptj01LAzEQhoMoWKv_wEPAa3fN12Y3x1L8gqKX3kuaTNaUbSKb7de_N1KRHmQOM_PyzDszCN1TUlJe08d13PZBd-VXDFAS1lAu-QUaUcVZIRnhl2f1NbpJaU1IxRspRygu9hHHw3GIxgess0ts0wS_F7jtjlmCCfbBbg3g7QB97rGJYei1GXwMCcMB7_wuZgbv9THh4VMP2HrnoMeuj5uTEN3filt05XSX4O43j9Hi-Wkxey3mHy9vs-m8aGUtCgaMSOWcFtpZoxWByhKzIg1VVlmouDVEVKCU5YRVxNHGrYRiK1cLB7YGPkYPJ9tWd7D0wcWfmzc-meW05lJQziqRqfIfKoeFjc9_gvNZPxv4BhX8b4o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Two oxytocin analogs, N- glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin</title><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Cherepanov, Stanislav M ; Yuhi, Teruko ; Iizuka, Takashi ; Hosono, Takashi ; Ono, Masanori ; Fujiwara, Hiroshi ; Yokoyama, Shigeru ; Shuto, Satoshi ; Higashida, Haruhiro</creator><creatorcontrib>Cherepanov, Stanislav M ; Yuhi, Teruko ; Iizuka, Takashi ; Hosono, Takashi ; Ono, Masanori ; Fujiwara, Hiroshi ; Yokoyama, Shigeru ; Shuto, Satoshi ; Higashida, Haruhiro</creatorcontrib><description>Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with other uterotonics for cases of refractory uterine atony. However, as the effect of OT dose on uterine contraction and control of blood loss during cesarean delivery for labor arrest are highly associated with side effects, small amounts of uterotonics may be used to elicit rapid and superior uterine contraction. We have previously synthesized OT analogs 2 and 5, prolines at the 7.sup.th positions of which were replaced with N-(p-fluorobenzyl) glycine [thus, compound 2 is now called fluorobenzyl (FBOT)] or N-(3-hydroxypropyl) glycine [compound 5 is now called hydroxypropyl (HPOT)], which exhibited highly potent binding affinities for human OT receptors in vitro. In this study, we measured the ex vivo effects of FBOT and HPOT on contractions of uteri isolated from human cesarean delivery samples and virgin female mice. We evaluated the potency and efficacy of the analogs on uterine contraction, additivity with OT, and the ability to overcome the effects of atosiban, an OT antagonist. In human samples, the potency rank judged by the calculated EC.sub.50 (pM) was as follows: HPOT (189) &gt; FBOT (556) &gt; OT (5,340) &gt; carbetocin (12,090). The calculated Emax was 86% for FBOT and 75% for HPOT (100%). Recovery from atosiban inhibition after HPOT treatment was as potent as that after OT treatment. HPOT showed additivity with OT. FBOT (56 pM) was found to be the strongest agonist in virgin mouse uterus. HPOT and FBOT demonstrated high potency and partial agonist efficacy in the human uterus. These results suggested that HPOT and FBOT are highly uterotonic for the human uterus and performed better than OT, indicating that they may prevent postpartum hemorrhage.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0281363</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Glycine ; Health aspects ; Oxytocin</subject><ispartof>PloS one, 2023-02, Vol.18 (2), p.e0281363</ispartof><rights>COPYRIGHT 2023 Public Library of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,862,27911,27912</link.rule.ids></links><search><creatorcontrib>Cherepanov, Stanislav M</creatorcontrib><creatorcontrib>Yuhi, Teruko</creatorcontrib><creatorcontrib>Iizuka, Takashi</creatorcontrib><creatorcontrib>Hosono, Takashi</creatorcontrib><creatorcontrib>Ono, Masanori</creatorcontrib><creatorcontrib>Fujiwara, Hiroshi</creatorcontrib><creatorcontrib>Yokoyama, Shigeru</creatorcontrib><creatorcontrib>Shuto, Satoshi</creatorcontrib><creatorcontrib>Higashida, Haruhiro</creatorcontrib><title>Two oxytocin analogs, N- glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin</title><title>PloS one</title><description>Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with other uterotonics for cases of refractory uterine atony. However, as the effect of OT dose on uterine contraction and control of blood loss during cesarean delivery for labor arrest are highly associated with side effects, small amounts of uterotonics may be used to elicit rapid and superior uterine contraction. We have previously synthesized OT analogs 2 and 5, prolines at the 7.sup.th positions of which were replaced with N-(p-fluorobenzyl) glycine [thus, compound 2 is now called fluorobenzyl (FBOT)] or N-(3-hydroxypropyl) glycine [compound 5 is now called hydroxypropyl (HPOT)], which exhibited highly potent binding affinities for human OT receptors in vitro. In this study, we measured the ex vivo effects of FBOT and HPOT on contractions of uteri isolated from human cesarean delivery samples and virgin female mice. We evaluated the potency and efficacy of the analogs on uterine contraction, additivity with OT, and the ability to overcome the effects of atosiban, an OT antagonist. In human samples, the potency rank judged by the calculated EC.sub.50 (pM) was as follows: HPOT (189) &gt; FBOT (556) &gt; OT (5,340) &gt; carbetocin (12,090). The calculated Emax was 86% for FBOT and 75% for HPOT (100%). Recovery from atosiban inhibition after HPOT treatment was as potent as that after OT treatment. HPOT showed additivity with OT. FBOT (56 pM) was found to be the strongest agonist in virgin mouse uterus. HPOT and FBOT demonstrated high potency and partial agonist efficacy in the human uterus. These results suggested that HPOT and FBOT are highly uterotonic for the human uterus and performed better than OT, indicating that they may prevent postpartum hemorrhage.</description><subject>Glycine</subject><subject>Health aspects</subject><subject>Oxytocin</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptj01LAzEQhoMoWKv_wEPAa3fN12Y3x1L8gqKX3kuaTNaUbSKb7de_N1KRHmQOM_PyzDszCN1TUlJe08d13PZBd-VXDFAS1lAu-QUaUcVZIRnhl2f1NbpJaU1IxRspRygu9hHHw3GIxgess0ts0wS_F7jtjlmCCfbBbg3g7QB97rGJYei1GXwMCcMB7_wuZgbv9THh4VMP2HrnoMeuj5uTEN3filt05XSX4O43j9Hi-Wkxey3mHy9vs-m8aGUtCgaMSOWcFtpZoxWByhKzIg1VVlmouDVEVKCU5YRVxNHGrYRiK1cLB7YGPkYPJ9tWd7D0wcWfmzc-meW05lJQziqRqfIfKoeFjc9_gvNZPxv4BhX8b4o</recordid><startdate>20230209</startdate><enddate>20230209</enddate><creator>Cherepanov, Stanislav M</creator><creator>Yuhi, Teruko</creator><creator>Iizuka, Takashi</creator><creator>Hosono, Takashi</creator><creator>Ono, Masanori</creator><creator>Fujiwara, Hiroshi</creator><creator>Yokoyama, Shigeru</creator><creator>Shuto, Satoshi</creator><creator>Higashida, Haruhiro</creator><general>Public Library of Science</general><scope/></search><sort><creationdate>20230209</creationdate><title>Two oxytocin analogs, N- glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin</title><author>Cherepanov, Stanislav M ; Yuhi, Teruko ; Iizuka, Takashi ; Hosono, Takashi ; Ono, Masanori ; Fujiwara, Hiroshi ; Yokoyama, Shigeru ; Shuto, Satoshi ; Higashida, Haruhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g674-2e2069ffa4afdca90e5d0cb0819d9de53dc045e99d30250f18fb492bf74fed7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Glycine</topic><topic>Health aspects</topic><topic>Oxytocin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cherepanov, Stanislav M</creatorcontrib><creatorcontrib>Yuhi, Teruko</creatorcontrib><creatorcontrib>Iizuka, Takashi</creatorcontrib><creatorcontrib>Hosono, Takashi</creatorcontrib><creatorcontrib>Ono, Masanori</creatorcontrib><creatorcontrib>Fujiwara, Hiroshi</creatorcontrib><creatorcontrib>Yokoyama, Shigeru</creatorcontrib><creatorcontrib>Shuto, Satoshi</creatorcontrib><creatorcontrib>Higashida, Haruhiro</creatorcontrib><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cherepanov, Stanislav M</au><au>Yuhi, Teruko</au><au>Iizuka, Takashi</au><au>Hosono, Takashi</au><au>Ono, Masanori</au><au>Fujiwara, Hiroshi</au><au>Yokoyama, Shigeru</au><au>Shuto, Satoshi</au><au>Higashida, Haruhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two oxytocin analogs, N- glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin</atitle><jtitle>PloS one</jtitle><date>2023-02-09</date><risdate>2023</risdate><volume>18</volume><issue>2</issue><spage>e0281363</spage><pages>e0281363-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Contraction of the uterus is critical for parturient processes. Insufficient uterine tone, resulting in atony, can potentiate postpartum hemorrhage; thus, it is a major risk factor and is the main cause of maternity-related deaths worldwide. Oxytocin (OT) is recommended for use in combination with other uterotonics for cases of refractory uterine atony. However, as the effect of OT dose on uterine contraction and control of blood loss during cesarean delivery for labor arrest are highly associated with side effects, small amounts of uterotonics may be used to elicit rapid and superior uterine contraction. We have previously synthesized OT analogs 2 and 5, prolines at the 7.sup.th positions of which were replaced with N-(p-fluorobenzyl) glycine [thus, compound 2 is now called fluorobenzyl (FBOT)] or N-(3-hydroxypropyl) glycine [compound 5 is now called hydroxypropyl (HPOT)], which exhibited highly potent binding affinities for human OT receptors in vitro. In this study, we measured the ex vivo effects of FBOT and HPOT on contractions of uteri isolated from human cesarean delivery samples and virgin female mice. We evaluated the potency and efficacy of the analogs on uterine contraction, additivity with OT, and the ability to overcome the effects of atosiban, an OT antagonist. In human samples, the potency rank judged by the calculated EC.sub.50 (pM) was as follows: HPOT (189) &gt; FBOT (556) &gt; OT (5,340) &gt; carbetocin (12,090). The calculated Emax was 86% for FBOT and 75% for HPOT (100%). Recovery from atosiban inhibition after HPOT treatment was as potent as that after OT treatment. HPOT showed additivity with OT. FBOT (56 pM) was found to be the strongest agonist in virgin mouse uterus. HPOT and FBOT demonstrated high potency and partial agonist efficacy in the human uterus. These results suggested that HPOT and FBOT are highly uterotonic for the human uterus and performed better than OT, indicating that they may prevent postpartum hemorrhage.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0281363</doi></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2023-02, Vol.18 (2), p.e0281363
issn 1932-6203
1932-6203
language eng
recordid cdi_gale_infotracmisc_A736413254
source DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Glycine
Health aspects
Oxytocin
title Two oxytocin analogs, N- glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T22%3A08%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two%20oxytocin%20analogs,%20N-%20glycine,%20induce%20uterine%20contractions%20ex%20vivo%20in%20ways%20that%20differ%20from%20that%20of%20oxytocin&rft.jtitle=PloS%20one&rft.au=Cherepanov,%20Stanislav%20M&rft.date=2023-02-09&rft.volume=18&rft.issue=2&rft.spage=e0281363&rft.pages=e0281363-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0281363&rft_dat=%3Cgale%3EA736413254%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A736413254&rfr_iscdi=true